FEATURES

• Can Biologics Tackle Antibiotic Resistance?

  A strong interest in the development of antibody based agents.

• Pharma Slow To Take Advantage of Web

  Must use the internet to reach consumers.

• Asia’s Largest Pharmaceutical Event Set for July 2-4

  Pre-show coverage of 2nd International Pharmaceutical Expo & Conference.

LATEST NEWS FROM PBI

• Food and Drug Administration Press Releases

  FDA Prevents Two Dairies from Adulterating Animal Drugs and Food [Read More]

  The U.S. Food and Drug Administration announced today that the District Court for the District of New Mexico has enjoined Do-Rene and Clover Knolls Dairies and their owners, Douglas B. Handley and Irene Handley, from adulterating new animal drugs and introducing adulterated food into commerce. Both companies are based in Clovis, N.M. Entire article

  FDA Announces Class I Recall of Ophthalmic Surgical Device [Read More]

  The U.S. Food and Drug Administration announced a Class I recall of lot no. UD30654 of Healon D, an ophthalmic viscosurgical device (OVD) manufactured by Advanced Medical Optics Inc. (AMO) of Santa Ana, Calif. Entire article

  FDA Approves First Nucleic Acid Test to Screen for Additional Types of HIV in Donated Blood and Tissue [Read More]

  The U.S. Food and Drug Administration today approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue. Entire article

  FDA Approves Drug for Patients with Advanced Prostate Cancer [Read More]

  The U.S. Food and Drug Administration recently approved the injectable drug degarelix, the first new drug in several years for prostate cancer. Degarelix is intended to treat patients with advanced prostate cancer. It belongs to a class of agents called gonadotropin releasing hormone (GnRH) receptor inhibitors. These agents slow the growth and progression of prostate cancer by suppressing testosterone, which plays an important role in the continued growth of prostate cancer. Entire article

• WebWire | News by Industry : Medical/Pharmaceuticals

  Epigentek Releases Kits for Complete and Systematic Detection of All Histone H3 Modification Patterns [Read More]

  NEW YORK, Jan 5 - Epigentek Group Inc. announced today that it released 24 commercial assay kits for detecting histone methylation patterns including mono-, di-, and tri- methylation changes at H3-K4,... [WebWire - Monday, January 05, 2009] Entire article

  Pursut.com Launches a Full-Service Recruitment Tool [Read More]

  GIG HARBOR, WA ? January 6, 2009 - Pursut.com announced today, that they will launch an innovative, online job board, specific to three industries; Healthcare, Energy and Specialized IT, which will si... [WebWire - Monday, January 05, 2009] Entire article

  Gene Variation May Lead to Early Cardiovascular Disease [Read More]

  Researchers at Duke University Medical Center have identified a variation in a particular gene that increases a person's susceptibility to early coronary artery disease. For years, scientists have kno... [WebWire - Monday, January 05, 2009] Entire article

  Frost & Sullivan Awards Toshiba America Medical Systems for Innovation in Cardiovascular Imaging Products and Services [Read More]

  MOUNTAIN VIEW, Calif. ? Based on its recent analysis of the cardiovascular imaging market, Frost & Sullivan recognizes Toshiba America Medical Systems with the 2008 North American Frost & Sullivan Awa... [WebWire - Monday, January 05, 2009] Entire article

• PBI Breaking News

  Battle for HIV drug market share getting fiercer [Read More]

  The HIV market, worth $9.3 billion in 2007, is expected to grow to $15.1 billion by 2017, driven by the increasing prevalence of HIV worldwide and the longer life expectancy of patients receiving trea... Entire article

  Is an Rx-to-OTC move the right prescription to protect pharma revenues & cut healthcare costs? [Read More]

  With the growing cost of developing novel drugs combined with the fact that from year-to-year fewer such drugs are gaining regulatory approval, the use by pharmaceutical companies of lifecycle managem... Entire article

  Is Cost Containment Impacting Pharmaceutical Innovation? [Read More]

  With the costs of providing healthcare spiraling, governments and payers across the seven major markets are implementing cost-cutting initiatives in an effort to combat these escalating healthcare cos... Entire article

  Monoclonal antibody sales to almost double in coming years [Read More]

  In 2007 total global monoclonal antibody (mAb) sales reached $26 billion and are forecast to almost double to $49 billion by 2013. While small molecule drug sales will continue to make up the majority... Entire article

MEETINGS / EVENTS